ciprofibrate (Compound)

Synonyms:Ciprofibrate, 52214-84-3, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid, Lipanor, Ciprofibratum, 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, Ciprofibrato, Modalim, WIN 35833, Win-35833, Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-, 2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid, MFCD00467135, 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid, NSC-759617, F8252JGO9S, DTXSID8020331, CHEBI:50867, Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-, NCGC00164447-01, 2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid, Ciprofibratum [INN-Latin], DTXCID20331, Ciprofibrato [INN-Spanish], Hiperlipen, Ciprol, SMR000857190, CCRIS 173, SR-01000075734, EINECS 257-744-6, Ciprofibrate (USAN/INN), BRN 1984981, UNII-F8252JGO9S, 2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acid, Ciprofibrate?, Ciprofibrate [USAN:INN:BAN], CAS-52214-84-3, Ciprofibrate- Bio-X, 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, Prestwick0_001076, Prestwick1_001076, Prestwick2_001076, Prestwick3_001076, CIPROFIBRATE [MI], CIPROFIBRATE [INN], C 0330, CIPROFIBRATE [USAN], Lopac0_000168, SCHEMBL26870, BSPBio_001092, CIPROFIBRATE [MART.], MLS002154143, MLS006011758, CIPROFIBRATE [WHO-DD], Win35833, SPBio_002996, BPBio1_001202, CHEMBL557555, GTPL3438, BCPP000277, CIPROFIBRATE [EP IMPURITY], Ciprofibrate for system suitability, HMS1571G14, HMS2098G14, HMS2235J14, HMS3260B17, HMS3369B22, HMS3656P09, HMS3715G14, Pharmakon1600-01502008, CIPROFIBRATE [EP MONOGRAPH], BCP03728, HY-B0664, Tox21_112121, Tox21_201359, Tox21_302840, Tox21_500168, BBL010821, BDBM50371235, NSC759617, s2665, STK624758, AKOS005557843, Tox21_112121_1, AC-1018, BCP9000533, CCG-204263, DB09064, KS-1201, LP00168, NSC 759617, SDCCGSBI-0050156.P002, NCGC00015202-02, NCGC00015202-03, NCGC00015202-04, NCGC00015202-05, NCGC00015202-06, NCGC00015202-08, NCGC00015202-20, NCGC00015202-21, NCGC00093652-01, NCGC00093652-02, NCGC00256361-01, NCGC00258911-01, NCGC00260853-01, BD164311, BCP0726000148, AB00514032, C2667, EU-0100168, FT-0602946, SW197242-4, D03521, O10468, AB00514032_06, A828985, EN300-18557337, J-520054, Q3496452, SR-01000075734-1, SR-01000075734-4, SR-01000075734-7, BRD-A49358627-001-03-9, BRD-A49358627-001-10-4, 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid, Ciprofibrate, European Pharmacopoeia (EP) Reference Standard, 2-[4-[2,2-bis(chloranyl)cyclopropyl]phenoxy]-2-methyl-propanoic acid, Ciprofibrate for system suitability, European Pharmacopoeia (EP) Reference Standard

Pubchem:PUBCHEM:2763

Id:e44c9b5f-cea8-5052-b0c3-e297820d8674

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ciprofibrate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ciprofibrate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ciprofibrate.

Results found

Linked to

	Label	Description
	BRD-A49358627-001-10-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 00658 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00658; PubChem_CID:2763, FILE=drugcentral_drug_00658.json)
	ciprofibrate (3a31c285-9d94-4683-8597-dbcbb9713ad8) Collection (Entity type)	Metadatata for ciprofibrate
	ciprofibrate positively regulates AHNAK2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ciprofibrate negatively regulates STOM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ciprofibrate positively regulates MMP10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ciprofibrate positively regulates BHLHE41 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ciprofibrate positively regulates MARCKS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ciprofibrate indication Mixed hyperlipidemia (disorder) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	ciprofibrate negatively regulates MT1F Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS